Skip to main content

Science

The emerging cancer treatment that’s exciting scientists: ‘We’ve just scratched the surface on what’s possible’

After embarking on a trial of CAR T-cell therapy, actor Sam Neill announced he is cancer-free. Researchers are enthusiastic the therapies c…

Newsorga deskPublished 3 min read
Illustration for: The emerging cancer treatment that’s exciting scientists: ‘We’ve just scratched the surface on what’s possible’

After embarking on a trial of CAR T-cell therapy, actor Sam Neill announced he is cancer-free. Researchers are enthusiastic the therapies could be a major weapon in the battle against cancer Follow our Australia news live blog for latest updates Get our breaking news email, free app or daily news podcast “Game-changer.” That’s how Prof Misty Jenkins, an immunologist at the Walter and Eliza Hall Institute of Medical Research, describes CAR T-cell therapy, an emerging but still costly cancer treatment that supercharges the body’s immune system to fight disease. Late last month, Jurassic Park actor Sam Neill put the treatment in the spotlight, revealing his stage three cancer was in remission after undergoing CAR T-cell therapy as part of a clinical trial in Sydney. He stopped short of describing his remission as a miracle – the success, he said, was “science at its best”. Continue reading...

This science item moved quickly across wires and feeds; the framing reflects how publishers were positioning the story on 2026-05-09.

Preprints, conference abstracts, and press-office summaries can diverge from the peer-reviewed record. When a study is still new, prioritize the journal PDF, author data availability statements, and any independent replication chatter in specialist communities.

Why this is on Newsorga: we keep a running index of major headlines so readers can scan context, then open the originating outlet for the full narrative, multimedia, and any corrections the publisher posts after first publication.

What can still change: sequencing of events, official counts, names of people involved before next-of-kin notification, and legal charges. Fast news is provisional by nature—especially when courts, hospitals, or battlefield fog are in play.

Primary reporting, photography, and interactive graphics belong to The Guardian. Continue reading the canonical version here: https://www.theguardian.com/society/2026/may/10/cancer-treatment-car-t-cell-therapy-sam-neill (opens in a new tab)

Newsorga’s desk format adds structure and navigation only. If you spot a factual mismatch between this page and the publisher, trust the publisher’s updated version.

Author profile

Newsorga desk

Reporting desk · 14 years’ experience

Staff-edited wire and field notes turned into clear explainers—signed when a single reporter owns the file.